Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b studyGlenda Gray, James G. Kublin, Koleka Mlisana et al.|The Lancet Infectious Diseases|2011Cited by 385
Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120–MF59 in AdultsGlenda Gray, Lubbe Wiesner, Linda‐Gail Bekker et al.|New England Journal of Medicine|2021Cited by 231
Estimating the contribution of key populations towards HIV transmission in South AfricaJack Stone, Peter Vickerman, Christinah Mukandavire et al.|Journal of the International AIDS Society|2021Cited by 71